Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.48%Return on Assets
VS
Market
Sector
Industry
History
$ 15.41Close
$ 9.55 - $ 70 52-Week Range
Ticker Information
Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKEROS THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KROS - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 757.16M | $ 18.77M | 2.48% |
| 3/31/2025 | $ 784.56M | $ 4.21M | 0.54% |
| 12/31/2024 | $ 615.89M | $ -187.35M | -30.42% |
| 9/30/2024 | $ 579.27M | $ -181.57M | -31.34% |
| 6/30/2024 | $ 455.02M | $ -168.05M | -36.93% |
| 3/31/2024 | $ 485.82M | $ -160.3M | -33% |
| 12/31/2023 | $ 370.02M | $ -152.99M | -41.35% |
| 9/30/2023 | $ 326.25M | $ -142.47M | -43.67% |
| 6/30/2023 | $ 356.31M | $ -126.54M | -35.51% |
| 3/31/2023 | $ 384.44M | $ -116.3M | -30.25% |
Key Performance Insights, Last 5 Years
- KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at 0%.
- Over the past 5 years, KEROS THERAPEUTICS INC's average ROA has been -27.18%.
- The median ROA for KEROS THERAPEUTICS INC during this period was -30.42%
- KEROS THERAPEUTICS INC reached its highest ROA over the past 5 years at 2.48%.
- The lowest ROA recorded by KEROS THERAPEUTICS INC in the same timeframe -43.67%
KEROS THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for KEROS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Assets [ $ 138.25M ]
(=) ROA [ 0% ] KROS - Return on Assets, Last 5 years
-43.67%
Minimum
Sep 30, 2023
2.48%
Maximum
Jun 30, 2025
-27.18%
Average
-30.42%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.07% with a standard deviation of 10.68%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.51% |
| max | 33.98% |
| average | 0.07% |
| median | 1.52% |
| std | 10.68% |